To the Editor— Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification?

Boyoung Joung; Professor Gregory Lip

doi:10.1016/j.hrthm.2019.04.006

Back

To the Editor— Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification?

Letter 2019 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Letter2018

Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy

Hyunjean Jung, Jung‐Hoon Sung, Pil‐Sung Yang, Eunsun Jang, Hee Tae Yu, Tae‐Hoon Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung, Professor Gregory Lip

Letter2020

Stroke risk stratification in hypertrophic cardiomyopathy

Juqian Zhang, Tatjana Potpara, Professor Gregory Lip

Article2019

Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study

Hyunjean Jung, Pil‐Sung Yang, Jung‐Hoon Sung, Eunsun Jang, Hee Joon Yu, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Professor Gregory Lip, Boyoung Joung

Letter2021

Should we make the risk stratification process more complex in patients with atrial fibrillation?

José Miguel Rivera‐Caravaca, Peter Brønnum Nielsen, Professor Gregory Lip

Letter2024

Residual Stroke Risk in Patients With Atrial Fibrillation following Transcatheter Aortic Valve Implantation: What Else Can We Do to Mitigate Risk?

Meng Li, Laurent Fauchier, Professor Gregory Lip